Elis Pharmaceuticals, a company that develops, manufactures and markets branded products and over the counter generic medications, continues to gain…

The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) represents the region’s leading innovative biopharmaceutical research…

With the corporate objective of having 75 percent of the company’s revenue coming from international markets by 2020, Laboratoires Expanscience is…

AKI Investments, under the Alphamed brand, is one of the leading distributors and service providers for the healthcare industry in the Middle East.…

Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at astounding rates in the Middle East…

From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management…

Genpharm is a Dubai-based regional company providing market access and marketing solutions for rare disease products in the MENA region. Co-Founders…

Mediclinic Middle East, the largest private healthcare group in the UAE, is betting on the continuum of care to continue thriving in a highly…

Eli Lilly’s president and general manager for the SAMETA (South Asia, Middle East, Turkey, and Africa) region, José Antonio Alas, discusses the…

Mundipharma, through its model of independent associated companies, is aiming to take the lead in the Middle East, Turkey & Africa markets through…

Vishnu Kalra, Janssen’s managing director for the GCC region, reflects on his 18-year career with Johnson & Johnson, including his perspective…

The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of decisions and legislation to support…